Skip to search formSkip to main contentSkip to account menu

bopindolol

Known as: 1-(tert-butylamino)-3-((2-methylindo)-4-yl)-2-propanol benzoate, 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((2-methyl-1H-indol-4-yl)oxy)-, benzoate (ester), (+-)- 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Adrenergic beta-AntagonistsPindolol

Narrower (1)

Sandonorm
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
An Update of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in the Treatment of Mild to Moderate Hypertension
  • N.M.
  • 2012
  • Corpus ID: 261425211
Various sections of the manuscript reviewed by: N.D. Borhani, Carnelian Bay, California, USA; M. Epstein, Nephrology Section, VA… 
1990
1990
Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.
1. The effect of withdrawal of atenolol and bopindolol administration was studied in 12 normal volunteers; six on each drug. 2… 
1988
1988
Subjective tolerance and age‐independent antihypertensive efficacy of treatment with bopindolol in general practice
Beta-blockers are now well established as alternative first-line drugs for the treatment of hypertension. Bopindolol is a new… 
1988
1988
Effect of a new beta‐blocker, bopindolol, on haemodynamics and cardiac function of patients with essential hypertension: an acute and chronic investigation
In patients with essential hypertension, both acute and chronic administration of bopindolol significantly lowered systolic and… 
1986
1986
Effect of bopindolol on the circadian blood pressure profile in essential hypertension.
The effect of bopindolol on circadian blood pressure and heart rate profile was evaluated by means of an automatic recording… 
1986
1986
Dose-finding study with bopindolol in arterial hypertension.
Bopindolol is a new beta blocker with a long duration of action which exerts antihypertensive effects at very low dosage. The aim… 
1986
1986
Influence of atenolol and bopindolol on circadian heart rate.
The effects of a cardioselective beta-adrenoceptor blocker without intrinsic sympathomimetic activity (ISA) (atenolol) and a… 
1986
1986
Pharmacodynamic models of various beta blockers: an explanation for the long duration of action of bopindolol.
Models describing the time course of effects (pharmacodynamic models) of various beta blockers in man are used to explain the… 
1986
1986
Interindividual pharmacokinetic and pharmacodynamic variability of different beta blockers.
Hepatic drug metabolism influenced by genetic and environmental factors is a major source of variation in the response to a… 
1983
1983
Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
In a randomized parallel-group trial the blood-pressure lowering effect of a new beta-adrenoceptor blocker bopindolol (LT 31-200…